A Cost-Benefit Analysis of the COVID-19 Asymptomatic Mass Testing Strategy in the North Metropolitan Area of Barcelona

Background: The epidemiological situation generated by COVID-19 has highlighted the importance of applying non-pharmacological measures in the management of the epidemic. Mass screening of the asymptomatic general population has been established as a priority strategy by carrying out diagnostic test...

Descripción completa

Detalles Bibliográficos
Autores principales: López Seguí, Francesc, Estrada Cuxart, Oriol, Mitjà i Villar, Oriol, Hernández Guillamet, Guillem, Prat Gil, Núria, Maria Bonet, Josep, Isnard Blanchar, Mar, Moreno Millan, Nemesio, Blanco, Ignacio, Vilar Capella, Marc, Català Sabaté, Martí, Aran Solé, Anna, Argimon Pallàs, Josep Maria, Clotet, Bonaventura, Ara del Rey, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297108/
https://www.ncbi.nlm.nih.gov/pubmed/34209328
http://dx.doi.org/10.3390/ijerph18137028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297108/
https://www.ncbi.nlm.nih.gov/pubmed/34209328
http://dx.doi.org/10.3390/ijerph18137028

Ejemplares similares